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Abstract  
Background: Cognitive Remediation (CR) aims primarily to improve cognition and functional 
outcomes. However, a limited number of studies reported a positive effect on symptoms. 
This limited effect may be because the symptom clusters considered are too broad and 
heterogeneous. This study explores, for the first time, the effect of CR on five empirically 
defined symptom dimensions of schizophrenia.  
 Method: Participants were patients with schizophrenia taking part in a randomised 
controlled trial comparing CR plus treatment as usual (CR, N=43) to treatment as usual (TAU, 
N=42). All participants were assessed at baseline and 14-weeks (i.e. at the conclusion of 
treatment for the CR group) with the Positive and Negative Symptoms Scale (PANSS). Five 
symptoms dimensions were derived from the PANSS scores: Positive (POS), Negative (NEG), 
Disorganised (DIS), Excited (EXC) and Emotional Distressed (EMD).  
Results: After CR, the therapy group had a significant reduction in DIS and NEG symptom 
dimensions compared to the TAU group. The traditional PANSS factors showed no effect of 
CR on symptoms. 
Conclusion: CR can have a positive effect on disorganisation but also on negative symptoms. 
Using detailed symptom dimensions can characterise more accurately the effect of CR on 
symptom of schizophrenia.  
 
 
Keywords: Cognitive Remediation; Cognition; Positive symptoms; Negative symptoms; 
PANSS.  
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Introduction  
Although not an elective target for Cognitive Remediation (CR), a number studies 
have reported that CR has a small effect on symptoms of schizophrenia (Wykes et al., 2011). 
The majority of studies reporting a positive effect found that CR reduced negative 
symptoms (Klingberg et al., 2011; Gharaeipour et al 2012). The effect of CR on negative 
symptoms is consistent with a few reports of an association between negative symptoms 
and cognitive problems (Milev et al., 2005; Ventura et al., 2009). 
Symptom assessment in CR studies is generally conducted for screening purposes 
and considered as a secondary outcome. The majority of studies assessed symptoms with 
the Positive and Negative Syndrome Scale (PANSS) using the original distinction proposed 
between positive, negative and general symptoms (Kay et al., 1987). In the last two decades 
an intense debate on the PANSS factorial structure advanced a number of new empirically 
based factorial solutions (White, 2005). Most of these factor analytic studies suggest that 
the PANSS should be considered as a 5-factor scale, but there is little consensus on item 
loading and factor names (Emsley et al., 2003; Lancon et al., 2000). Notably, Van der Gaag 
and colleagues (2006) attempted a resolution of this debate by considering all the 25 five-
factor solutions published but a stronger solution failed to emerge. More recently, Wallwork 
et al., (2012), advanced a five-factor consensus solution based on the most reliable items 
found across all the solutions published. This solution has proven reliable and likely to 
accommodate all the discrepancies that analytic techniques could not account for 
(Rodriguez-Jimenez et al., 2013).  
 In this study we explore whether the consensus 5-factor structure advanced by 
Wallwork et al., (2012) can better capture changes following a course of CR compared to the 
traditional 3-factor solution. No previous study has ever explored the effect of CR beyond 
the positive, negative and general symptoms distinction proposed in the original version of 
the PANSS (Kay et al., 1987). The 5-factor structure used here can provide additional 
knowledge in two important areas. Firstly, it will explore, for the first time, the effect of CR 
on symptoms dimensions such as, mood, excitement and disorganization with this latter 
dimension measuring a problem area likely to be affected by CR. Secondly, assess the 
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relevance of using empirically validated factor solutions for positive and negative 
dimensions as opposed to the conventional items. 
 
Method 
Study design 
The data for this study were from a single blind randomised controlled trial of 
cognitive remediation plus treatment-as-usual (CR) versus a treatment-as-usual (TAU) 
control. Assessments of cognition, symptoms and functioning were carried out at week 0 
and 14. For further details of the trial design see Wykes et al., (2007). Trial Registration: 
ISRCTN44277627 [controlled-trials.com]. 
Participants 
Eighty five participants were recruited from community mental health teams in 
South London, UK. Inclusion criteria: (i) DSM-IV diagnosis of schizophrenia, (ii) aged 17 - 66, 
(iii) evidence of executive or memory problems (more than one standard deviation below 
the normative mean on the Rivermead Behavioural Memory Test (Wilson et al., 1999), 
Hayling Test or the Wisconsin Card Sorting Task (Heaton et al., 1993; Burgess and Shallice, 
1996). Exclusion criteria: (i) current plans to change medication, (ii) evidence of a premorbid 
learning disability, (iii) primary DSM-IV substance abuse, or (iv) evidence of head injury or 
organic disorder. Five participants (i.e. 2 in the CR and 3 in the TAU group) did not complete 
the PANSS and/or left the study and could not be included in the analysis. 
Measures 
Positive and negative syndrome scale (PANSS, Kay et al., 1987)  
This is a 30-item measure of symptom severity for schizophrenia. The measure is 
administered as a clinical interview by a trained researcher or clinician. Each item can be 
scored on a 7-point scale ranging from not symptomatic (i.e. 1) to extremely severe 
symptom (i.e. 7). For this study we first scored the PANSS according to Kay et al (1987) and 
used its three factors: Positive (K_Pos), Negative (K_Neg) and General (K_Gen).  We also 
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scored the PANSS according to Wallwork et al., (2012) and extracted five factors:  Positive 
Symptoms (W_Pos), Negative Symptoms (W_Neg), Disorganised (W_Dis), Excited (W_Exc) 
and Negative Emotion Depressed (W_Emd). W_Pos included four items (i.e. P1, P3, P5 and 
G9); W_Neg included six items (i.e. N1, N2, N3, N4, N6 and G7); W_Dis included four items 
(i.e. P2, N5, G10 and G11); W_Exc included four items (i.e. P4, P7, G8 and G14); W_Emd 
included three items (i.e. G2, G3 and G6). 
 
Therapy 
This is a 40 session individual therapy involving a number of tasks targeting executive 
function, attention, working memory and long-term memory (Wykes & Reeder, 2005). It 
takes place at least three days per week and is conducted by trained graduate psychologists. 
The intervention is manual-based but sessions are tailored to the individual, according to 
their cognitive strengths and difficulties, and gradually increase in difficulty over the course 
of therapy. Sessions comprise a series of tasks which are highly repetitive and taught using 
errorless learning and scaffolding training techniques. The therapy aims to improve the 
participant’s approach to tasks so that it becomes systematic, organised and highly 
strategic. The therapy also emphasises the importance of metacognitive knowledge of 
cognitive strengths and difficulties and encourages participants to transfer new cognitive 
skills to everyday life (see Wykes & Reeder, 2005 for further details).  
 
Analysis 
ANCOVA was used to explore the effect of therapy on each of the symptom factors 
according to the solution proposed by Kay et al., (1987) and Wallwork et al., (2012). Level of 
symptom at post-therapy was entered as a dependent variable and, therapy group was 
entered as the independent variable.  Baseline symptom level was entered in the model as 
covariate.  
Results 
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At baseline participants in the CR group had comparable levels of symptoms compared to 
participants in the TAU group (Table 1). The effects of cognitive remediation on objective 
cognitive measures are reported in Wykes et al., (2007). 
----- Table 1 about here---- 
 ANCOVA conducted to investigate the effect of CR on the factors proposed by Kay et al., 
1987 yield no significant difference between the groups. Amongst the factors proposed by  
Kay et al., the best fitting model was for K_Neg, F(2, 80)=3.3, p=0.08, partial η
2
=0.03.  
The same analysis conducted for the Wallwork et al., factors showed no significant 
interaction between therapy group and factor for W_Pos, W_Exc and W_Emd (all models 
p>0.05). Differently models conducted for negative symptoms and cognitive disorganisation 
showed significant change in favour of the CR group:  W_Neg, F(2, 80)=21.1, p<.0001, partial 
η
2
=0.07,  and W_Dis, F(2, 80)=14.2, p<.0001, partial η
2
=0.1.  
 
Discussion 
The results of this study demonstrated that CR can have a positive impact on 
particular symptom domains of schizophrenia. In this study we assessed symptoms domains 
using the two factorial solutions of the PANSS: the solution originally proposed by Kay et al., 
(1987) and a more recent consensus 5-factor solution proposed by Wallwork et al., (2012). 
The Wallwork and colleagues solution provides a more refined description of symptom 
dimensions compared to the traditional 3-factor solution. In particular, the inclusion of a 
disorganisation factor seems relevant for the evaluation of CR programs as improvement in 
this domain is expected and may mirror functional improvements.  
In line with some previous studies the current results showed an effect of CR on the 
negative symptoms cluster (Klingberg et al., 2011; Gharaeipour et al., 2012). The 
relationship between negative symptoms and cognitive problems is variably reported in the 
literature and may be largely influenced by the type of symptoms considered (Harvey et al., 
2006; Ventura et al., 2010). Our results show that this relationship may only be apparent 
when considering a narrower and more homogeneous set of symptoms. The solution 
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proposed by Wallwork et al (2012) includes in the negative factor items from the general 
complex (e.g. motor retardation) and excluding items related to cognitive processes (e.g. 
difficult in abstraction). The items in this solution appear to define more precisely the 
behavioural and the expressive elements of negative symptoms and provide an assessment 
of this domain better aligned with recent empirical findings (Daneluzzo et al., 2002; 
Messinger, 2011; Liemburg et al., 2013).   
Perhaps unsurprisingly, as this appears as the most “cognitive” symptoms cluster, 
W_Dis scores significantly reduce following CR. This is the first time that a CR study showed 
changes in this domain. Reducing levels of disorganization is part of what CR is ultimately 
aiming to achieve as part of its larger goal of promoting community functioning. A possible 
reason for the improvement in this symptom complex could be the strategic approach 
promoted as part of the CR program used here (Wykes & Reeder, 2005; Cella et al., in 
press). Changes in this dimension would be quite difficult to observe in the traditional 
PANSS structure as the W_Dis factor items are drawn from the positive (e.g. conceptual 
disorganisation), negative (e.g. difficult in abstraction) and general scale (e.g. poor 
attention). The current findings also suggest that the measurement of gross cognitive 
problems could be achieved using clinical interviews. Clinicians may consider using these 
PANSS items to assess CR programs targeting disorganization in addition to 
neuropsychological testing. This can be particularly helpful in for screening and 
interventions targeting the early and prodromal phase of psychosis (Demjaha et al., 2012). 
This study has limitations. The sample is considered is not very large but enough to 
appreciate differences. These findings would need to be replicated in other studies before a 
clear recommendation on the use of the PANSS 5-factor structure can be advanced, 
particularly because the effect sizes are modest. Our findings are also limited to the type of 
CR used and may not extend other programs with reduced therapist contact.  
 In summary, the results of this study suggest that when specific symptoms 
dimensions are considered it is possible to observe a positive effect of CR. The 5-factor 
solution used in this study defines more precise and homogeneous symptoms dimensions 
which may be more appropriate to evaluate CR effectiveness. The results also show that 
reduction in disorganisation and negative symptoms could be expected after CR.   
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Table 1 Mean (SD) baseline and post-treatment values for PANSS Kay et al., (1987) three factors and 
Wallwork et al., (2012) five factors. 
PANSS factor Baseline Post-treatment 
 CRT 
(N=43) 
TAU 
(N=42) 
CRT 
(N=41) 
TAU 
(N=39) 
K_Pos 14.2 (5.4) 12.5 (4.9) 14.2 (5.4) 13.8 (6.4) 
K_Neg 18.6 (7.3) 16.6(7.2) 17.0 (6.6) 16.7 (7.1) 
K_Gen 30.1 (8.2) 27.5 (6.8) 27.4 (10.1) 29 (8.5) 
W_Pos 8.31 (4.1) 7.3 (3.6) 9.1 (5.5) 8.8 (5.2) 
W_Neg 15.4 (6.5) 13.2 (6.3) 13.6 (5.6) 13.7 (5.5) 
W_Dis 8.3 (3.1) 8.2 (2.6) 7 (2.3) 8.3 (2.8) 
W_Exc 5.4 (2.1) 5.3 (2.4) 5.5 (2.4) 5.6 (2.7) 
W_Emd 5.3 (2.6) 5.5 (2.4) 5.6 (3.2) 5.8 (2.1) 
Note: Kay et al., factors: Positive (K_Pos), Negative (K_Neg) and General (K_Gen). Wallwork et al., factors: Positive (W_Pos), Negative 
(W_Neg), Disorganised (W_Dis), Excited (W_Exc) and Negative Emotion Depressed (W_Emd). 
 
Table 1
The authors would like to acknowledge the support of the NIHR Biomedical Sciences 
Centre in Mental Health at the South London and Maudsley Foundation Trust and 
Institute of Psychiatry, King's College London. TW would like to acknowledge the 
NIHR for her Senior Investigator Award. 
 
Acknowledgement
None 
*Conflict of Interest
TW and CR secured funding and conducted the original study. MC did the analyses. 
MC and TW wrote the first draft of the paper. All authors contributed to the final 
version and have approved the final manuscript. 
 
*Contributors
